Toxins · 2024 · 62 citations · 22 references
MedicineNeurologyRehabilitation MedicineOrthoticsRehabilitationStroke RehabilitationNeuromuscular RehabilitationSpasticity ManagementSpasticity SurgeryStrokeStroke SurgeryBias In Systematic ReviewsGrade Evidence AssessmentOutcome Measurement In SpasticityPost-stroke Gait TrainingPost-stroke Motor RehabilitationPost-stroke RehabilitationRehabilitation After Spasticity SurgerySpasticity Management Indications
This article aims to provide a concise overview of the best available evidence for managing post-stroke spasticity. A modified scoping review, conducted following the PRISMA guidelines and the PRISMA Extension for Scoping Reviews (PRISMA-ScR), involved an intensive search on Medline and PubMed from 1 January 2000 to 31 August 2023. The focus was placed on high-quality (GRADE A) medical, rehabilitation, and surgical interventions. In total, 32 treatments for post-stroke spasticity were identified. Two independent reviewers rigorously assessed studies, extracting data, and evaluating bias using GRADE criteria. Only interventions with GRADE A evidence were considered. The data included the study type, number of trials, participant characteristics, interventions, parameters, controls, outcomes, and limitations. The results revealed eleven treatments supported by GRADE A evidence, comprising 14 studies. Thirteen were systematic reviews and meta-analyses, and one was randomized control trial. The GRADE A treatments included stretching exercises, static stretching with positional orthosis, transcutaneous electrical nerve stimulation, extracorporeal shock wave therapy, peripheral magnetic stimulation, non-invasive brain stimulation, botulinum toxin A injection, dry needling, intrathecal baclofen, whole body vibration, and localized muscle vibration. In conclusion, this modified scoping review highlights the multimodal treatments supported by GRADE A evidence as being effective for improving functional recovery and quality of life in post-stroke spasticity. Further research and exploration of new therapeutic options are encouraged.
22
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco, Erin Lillie, Wasifa Zarin et al. · Annals of Internal Medicine · 2018 · 40.4K citations · Full text
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022
Valery L. Feigin, Michael Brainin, Bo Norrving et al. · International Journal of Stroke · 2022 · 2.8K citations